Table 5. Distribution of different... | American Society of Hematology

Table 5.

Distribution of different karyotypic risk categories and Flt3-ITD mutations among groups of AML patients

	n	Flt3-ITD, no.	Risk karyotype, no.
	n	Flt3-ITD, no.	Favorable^5-150	Unfavorable^5-151	Intermediate/unknown^5-152
Group I,EVI1⁺ andMDS1-EVI1⁻	6	1	0	4	2
Group II, EVI1⁺ andMDS1-EVI1⁺	26	1	0	12	14
Group III, EVI1⁻ andMDS1-EVI1⁺	12	1	4	1	7
Group IV, EVI1⁻ andMDS1-EVI1⁻	275	82	53	33	189

	n	Flt3-ITD, no.	Risk karyotype, no.
	n	Flt3-ITD, no.	Favorable^5-150	Unfavorable^5-151	Intermediate/unknown^5-152
Group I,EVI1⁺ andMDS1-EVI1⁻	6	1	0	4	2
Group II, EVI1⁺ andMDS1-EVI1⁺	26	1	0	12	14
Group III, EVI1⁻ andMDS1-EVI1⁺	12	1	4	1	7
Group IV, EVI1⁻ andMDS1-EVI1⁻	275	82	53	33	189

t(8;21), t(15;17) or inv(16).

−7/7q-, −5/5q-, t(9;22), t(6;9) or complex karyotype (>3 abnormalities).

Other cytogenetic aberrations or normal karyotype.